Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 19 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 19, Issue 3 (September 2016) In this issue Reviews Original Articles Corrigendum Also new AOP Sign up for e-alerts Twitter Recommend to your library Web feed Subscribe Advertisement We are pleased to announce that the Impact Factor* for Prostate Cancer & Prostatic Diseases is now 3.803 - an increase from 3.425 last year. PCAN is ranked 12 of 77 titles in the urology & nephrology category and 64 of 213 in the oncology category. The journal would like to thank all our authors, reviewers and readers for their continued support. (*Thomson Reuters, 2015 Journal Citation Reports®)  Submit your research   Reviews Top PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges S P Rowe, M A Gorin, M E Allaf, K J Pienta, P T Tran, M G Pomper, A E Ross and S Y Cho Prostate Cancer Prostatic Dis 2016 19: 223-230; advance online publication, May 3, 2016; 10.1038/pcan.2016.13 Abstract | Full Text Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting E S Antonarakis, A J Armstrong, S M Dehm and J Luo Prostate Cancer Prostatic Dis 2016 19: 231-241; advance online publication, May 17, 2016; 10.1038/pcan.2016.17 Abstract | Full Text Original Articles Top MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor V Genitsch, I Zlobec, G N Thalmann and A Fleischmann Prostate Cancer Prostatic Dis 2016 19: 242-247; advance online publication, May 10, 2016; 10.1038/pcan.2016.11 Abstract | Full Text The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells OPEN C Morell, A Bort, D Vara, A Ramos-Torres, N Rodríguez-Henche and I Díaz-Laviada Prostate Cancer Prostatic Dis 2016 19: 248-257; advance online publication, June 21, 2016; 10.1038/pcan.2016.19 Abstract | Full Text The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial OPEN A El-Shater Bosaily, M Valerio, Y Hu, A Freeman, C Jameson, L Brown, R Kaplan, R G Hindley, D Barratt, M Emberton and H U Ahmed Prostate Cancer Prostatic Dis 2016 19: 258-263; advance online publication, July 12, 2016; 10.1038/pcan.2016.7 Abstract | Full Text Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies M S Tretiakova, W Wei, H D Boyer, L F Newcomb, S Hawley, H Auman, F Vakar-Lopez, J K McKenney, L Fazli, J Simko, D A Troyer, A Hurtado-Coll, I M Thompson, Jr, P R Carroll, W J Ellis, M E Gleave, P S Nelson, D W Lin, L D True, Z Feng and J D Brooks Prostate Cancer Prostatic Dis 2016 19: 264-270; advance online publication, May 3, 2016; 10.1038/pcan.2016.12 Abstract | Full Text Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural disease D E Spratt, J R Osborne, Z S Zumsteg, K Rebeiz, J Leeman, A Rivera, M J Morris and M J Zelefsky Prostate Cancer Prostatic Dis 2016 19: 271-276; advance online publication, April 26, 2016; 10.1038/pcan.2016.14 Abstract | Full Text Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk OPEN A E Ross, R B Den, K Yousefi, B J Trock, J Tosoian, E Davicioni, D J S Thompson, V Choeurng, Z Haddad, P T Tran, E J Trabulsi, L G Gomella, C D Lallas, F Abdollah, F Y Feng, E A Klein, A P Dicker, S J Freedland, R J Karnes and E M Schaeffer Prostate Cancer Prostatic Dis 2016 19: 277-282; advance online publication, May 3, 2016; 10.1038/pcan.2016.15 Abstract | Full Text Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance J P Radtke, T H Kuru, D Bonekamp, M T Freitag, M B Wolf, C D Alt, G Hatiboglu, S Boxler, S Pahernik, W Roth, M C Roethke, H P Schlemmer, M Hohenfellner and B A Hadaschik Prostate Cancer Prostatic Dis 2016 19: 283-291; advance online publication, May 17, 2016; 10.1038/pcan.2016.16 Abstract | Full Text Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up D E Spratt, W C Jackson, A Abugharib, S A Tomlins, R T Dess, P D Soni, J Y Lee, S G Zhao, A I Cole, Z S Zumsteg, H Sandler, D Hamstra, J W Hearn, G Palapattu, R Mehra, T M Morgan and F Y Feng Prostate Cancer Prostatic Dis 2016 19: 292-297; advance online publication, May 24, 2016; 10.1038/pcan.2016.18 Abstract | Full Text Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer W S Jang, K S Cho, K H Kim, C Y Yoon, Y J Kang, J Y Lee, W S Ham, K H Rha, S J Hong and Y D Choi Prostate Cancer Prostatic Dis 2016 19: 298-304; advance online publication, June 28, 2016; 10.1038/pcan.2016.20 Abstract | Full Text The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts A D Vandersluis, D E Guy, L H Klotz, N E Fleshner, A Kiss, C Parker and V Venkateswaran Prostate Cancer Prostatic Dis 2016 19: 305-310; advance online publication, June 28, 2016; 10.1038/pcan.2016.22 Abstract | Full Text PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure OPEN T T Shah, M Peters, A Kanthabalan, N McCartan, Y Fatola, J van der Voort van Zyp, M van Vulpen, A Freeman, C M Moore, M Arya, M Emberton and H U Ahmed Prostate Cancer Prostatic Dis 2016 19: 311-316; advance online publication, July 19, 2016; 10.1038/pcan.2016.23 Abstract | Full Text Impact of the extent of extraprostatic extension defined by Epstein’s method in patients with negative surgical margins and negative lymph node invasion T Maubon, N Branger, C Bastide, G Lonjon, K-A Harvey-Bryan, P Validire, S Giusiano, D Rossi, X Cathelineau and F Rozet Prostate Cancer Prostatic Dis 2016 19: 317-321; advance online publication, July 12, 2016; 10.1038/pcan.2016.24 Abstract | Full Text Corrigendum Top The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial OPEN A El-Shater Bosaily, M Valerio, Y Hu, A Freeman, C Jameson, L Brown, R Kaplan, R G Hindley, D Barratt, M Emberton and H U Ahmed Prostate Cancer Prostatic Dis 2016 19: 322; advance online publication, August 9, 2016; 10.1038/pcan.2016.37 Full Text Advertisement Meet the Editors of Prostate Cancer and Prostatic Diseases The Editors of Prostate Cancer and Prostatic Diseases are internationally renowned researchers at the top of their field. Our team of experts are widely published, with their breadth of knowledge and experience making them key figures in the field of prostate cancer and prostatic disease. Find out more about our Editors, their specific areas of expertise and whether your next paper is suitable for PCAN on our Meet the Editors page Learn more about submitting your research   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.